BioActor Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
BioActor General Information
Description
Developer of natural health ingredients designed to promote healthy living and general well-being. The company offers products that are used in functional foods, medical food, food supplements, and sports nutrition, thereby enabling clients to stay fit in the face of health concerns related to metabolic syndrome and aging such as diabetes, osteoporosis, and cardiovascular disease as well as in cases of excess cholesterol, blood pressure and bone-related issues.
Contact Information
Website
www.bioactor.comCorporate Office
- Maastricht Health Campus
- Gaetano Martinolaan 50
- 6229 GS Maastricht
- Netherlands
Corporate Office
- Maastricht Health Campus
- Gaetano Martinolaan 50
- 6229 GS Maastricht
- Netherlands
BioActor Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioActor Comparisons
Industry
Financing
Details
BioActor Competitors (2)
One of BioActor’s 2 competitors is Fytexia, a Formerly PE-Backed company based in Vendres, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fytexia | Formerly PE-Backed | Vendres, France | ||||
| Nexira | Formerly PE-Backed | Rouen, France |
BioActor Patents
BioActor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026087503-A1 | Non-therapeutic use of aronia extract for enhancing executive function | Pending | 22-Oct-2024 | ||
| WO-2025119974-A1 | Naringin or naringenin for improving sleep quality | Inactive | 04-Dec-2023 | ||
| WO-2024115646-A1 | Non-therapeutic use of an aronia berry extract | Inactive | 01-Dec-2022 | ||
| WO-2024079251-A1 | Non-therapeutic use of a composition comprising oleuropein | Inactive | 12-Oct-2022 | ||
| EP-3431093-A1 | Wheat-derived polysaccharides for reduction of antibiotic resistance | Inactive | 17-Jul-2017 | A61K31/715 |
BioActor Signals
BioActor Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioActor FAQs
-
When was BioActor founded?
BioActor was founded in 2011.
-
Where is BioActor headquartered?
BioActor is headquartered in Maastricht, Netherlands.
-
What is the size of BioActor?
BioActor has 15 total employees.
-
What industry is BioActor in?
BioActor’s primary industry is Other Consumer Non-Durables.
-
Is BioActor a private or public company?
BioActor is a Private company.
-
What is BioActor’s current revenue?
The current revenue for BioActor is .
-
How much funding has BioActor raised over time?
BioActor has raised $2.86M.
-
Who are BioActor’s investors?
BVP (Brightlands Venture Partners), Eurostars, Icos Capital, LIOF Nedermaas High Tech Ventures, and ScaleUpNation have invested in BioActor.
-
Who are BioActor’s competitors?
-
When was BioActor acquired?
BioActor was acquired on 22-Dec-2022.
-
Who acquired BioActor?
BioActor was acquired by Solabia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process